Alpha Cognition Inc C.ACOG

Alternate Symbol(s): ACOG

Healthcare Biotechnology

Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062 is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and as an intranasal formulation for Cognitive Impairment with mTBI. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS.

CSE:ACOG - Post by User

Alpha Cognition Inc > $ACOG - not much movement td

<< Previous

Bullboard Posts

Next >>

Comment by ferret_caon Oct 19, 2021 9:46am

93 Views

Post# 34021926

RE:$ACOG - not much movement td

a good blurb in the globe investor this morning, an analyst from iAcapital gives it $5 price target and basicaly says it has an exceptionally high probability of success.

I initiated a starting position at the open today, looks like a good entry point after the dip yesterday.

cheers ferret

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch